Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
Teva Wins Copaxone Protection
Forbes
Tue, 09/7/10 - 05:03 pm
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents
Novartis
Momenta
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Bloomberg
Mon, 08/30/10 - 11:18 am
Sanofi
MS
teriflunomide
Merck KGaA
multiple sclerosis
Novartis
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Wed, 07/28/10 - 10:22 am
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
Merck KGaA expects MS pill to lift drugs margin
Reuters
Wed, 06/30/10 - 10:00 am
Merck KGaA
multiple sclerosis
Gilenia
MS
Merck Serono
cladribine
Genzyme's MS drug gets FDA fast track
Yahoo/AP
Tue, 06/15/10 - 09:15 am
fast track
Genzyme
MS
multiple sclerosis
FDA
FDA Approval Positions Novartis in the Lead to Bring Oral MS Treatment to Market
Seeking Alpha
Mon, 06/14/10 - 12:05 pm
FDA
Novartis
MS
multiple sclerosis
FDA Panel Endorses Novartis Multiple Sclerosis Pill
Pharmalot
Thu, 06/10/10 - 08:38 pm
FDA
advisory panels
Novartis
MS
multiple sclerosis
Gilenia
FDA weighs benefits, risks of Novartis MS pill
Yahoo/AP
Tue, 06/8/10 - 06:57 pm
MS
FDA
multiple sclerosis
Gilenia
Merck KGaA again seeks U.S. nod for MS pill
Reuters
Tue, 06/8/10 - 08:37 am
Merck KGaA
multiple sclerosis
MS
cladribine
Teva reports encouraging data from study assessing new lower-volume injection of Copaxone at 24th CMSC
News-Medical
Sat, 06/5/10 - 12:10 pm
Teva Pharmaceuticals
Copaxone
multiple sclerosis
Biogen Idec Sues Other MS Drug Makers
WSJ Online
Wed, 06/2/10 - 05:16 pm
MS
multiple sclerosis
Biogen Idec
Pfizer
Bayer
Novartis
patents
beta-interferon
Safety Concerns Unlikely to Delay FDA Approval of Novartis' MS Drug Gilenia
BNET Pharma
Wed, 06/2/10 - 08:25 am
Novartis
MS
multiple sclerosis
Gilenia
FDA extends review on Novartis oral MS drug by three months
Pharma Times, UK
Tue, 05/25/10 - 09:02 am
FDA
Novartis
MS
multiple sclerosis
Gilenia
FDA Rejects 2nd Teva Citizen Petition Against Generic Copaxone
WSJ Online
Thu, 05/13/10 - 10:38 am
FDA
generics
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Mon, 04/19/10 - 10:57 am
Novartis
multiple sclerosis
MS
Biogen Idec
Merck
Genzyme's Dilemma: Its Cheap Cancer Drug Wants to Cannibalize a Potential MS Blockbuster
BNET Pharma
Fri, 04/16/10 - 11:16 am
Genzyme
cancer
MS
multiple sclerosis
Campath
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Thu, 04/15/10 - 09:58 am
MS
multiple sclerosis
Campath
Carl Icahn
Genzyme
Genzyme sees MS drug topping efficacy league
Reuters
Wed, 04/14/10 - 01:59 pm
Genzyme
Campath
multiple sclerosis
MS
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wed, 04/14/10 - 01:56 pm
MS
Acorda Therapeutics
AMPYRA
multiple sclerosis
Novartis moves closer to first oral MS treatment
Reuters
Tue, 04/13/10 - 09:58 am
Novartis
MS
multiple sclerosis
Gilenia
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
next ›
last »